|
|
Article: Surface Logix Inc. to Present at the RBC Capital Markets Healthcare Conference.
- Article from:
- PR Newswire
- Article date:
- December 11, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BOSTON, Dec. 11 /PRNewswire/ -- Surface Logix Inc. announced that Jim Mahoney, President and Chief Executive Officer, will participate on two panel discussions at the RBC Capital Markets Healthcare Conference this week at the Westin Times Square Hotel in New York.
During the "New Targets for Lipid Control" panel on Wednesday, December 13, 2006, from 9:00 to 9:55 AM, Mr. Mahoney will provide insight into the clinical development of SLx-4090, a first-in-class enterocyte-specific MTP inhibitor that acts selectively in the gastrointestinal tract to target unmet needs in dyslipidemia, metabolic disorders and obesity, and is entering a Phase 2a trial.
On ...